ES2053454T3 - Composiciones farmaceuticas que contienen peptidos del grupo de la colecistoquinina-ceruleina para la terapia de estados de shock y de insuficiencias respiratorias y cardiocirculatorias. - Google Patents
Composiciones farmaceuticas que contienen peptidos del grupo de la colecistoquinina-ceruleina para la terapia de estados de shock y de insuficiencias respiratorias y cardiocirculatorias.Info
- Publication number
- ES2053454T3 ES2053454T3 ES87100015T ES87100015T ES2053454T3 ES 2053454 T3 ES2053454 T3 ES 2053454T3 ES 87100015 T ES87100015 T ES 87100015T ES 87100015 T ES87100015 T ES 87100015T ES 2053454 T3 ES2053454 T3 ES 2053454T3
- Authority
- ES
- Spain
- Prior art keywords
- respiratory
- pharmaceutical compositions
- shock
- states
- cholecystocinin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 230000002425 cardiocirculatory effect Effects 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 2
- 230000000241 respiratory effect Effects 0.000 title abstract 2
- 230000035939 shock Effects 0.000 title abstract 2
- 102000004196 processed proteins & peptides Human genes 0.000 title 1
- 238000002560 therapeutic procedure Methods 0.000 title 1
- AOXOCDRNSPFDPE-UKEONUMOSA-N chembl413654 Chemical compound C([C@H](C(=O)NCC(=O)N[C@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@H](CCSC)C(=O)N[C@H](CC(O)=O)C(=O)N[C@H](CC=1C=CC=CC=1)C(N)=O)NC(=O)[C@@H](C)NC(=O)[C@@H](CCC(O)=O)NC(=O)[C@@H](CCC(O)=O)NC(=O)[C@@H](CCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H]1N(CCC1)C(=O)CNC(=O)[C@@H](N)CCC(O)=O)C1=CC=C(O)C=C1 AOXOCDRNSPFDPE-UKEONUMOSA-N 0.000 abstract 2
- 206010065929 Cardiovascular insufficiency Diseases 0.000 abstract 1
- 102400000921 Gastrin Human genes 0.000 abstract 1
- 108010052343 Gastrins Proteins 0.000 abstract 1
- 108010038807 Oligopeptides Proteins 0.000 abstract 1
- 102000015636 Oligopeptides Human genes 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 239000003937 drug carrier Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/2207—Gastrins; Cholecystokinins [CCK]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/16—Central respiratory analeptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Gastroenterology & Hepatology (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Endocrinology (AREA)
- Zoology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Pulmonology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Un procedimiento para la preparación de composiciones farmacéuticas para el tratamiento terapéutico de los estados de shock y de las insuficiencias respiratorias y cardiocirculatoria, caracterizado por constar de la operación de mezclar: (1) como principio activo, una cantidad farmacéuticamente efectiva de un péptido seleccionado entre: (a) gastrina, (b) los fragmentos de gastrina que comprende la secuencia tetrapeptídica L-triptofil-L-metionil-L -aspartil-L-fenilalanilamida y (c) el oligopéptido constituído exclusivamente por la secuencia tetrapeptídica L-triptofil-L-metionil-L -aspartil-L-fenilalanilamida, con (2) un excipiente farmacéuticamente aceptable.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT19055/86A IT1204430B (it) | 1986-01-10 | 1986-01-10 | Composizioni farmaceutiche comprendenti peptidi del gruppo colecistochinina-cerulina per il trattamento terapeutico degli stati di shock e dell'insufficienza respiratoria e cardiocircolatoria |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2053454T3 true ES2053454T3 (es) | 1994-08-01 |
Family
ID=11154164
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES87100015T Expired - Lifetime ES2053454T3 (es) | 1986-01-10 | 1987-01-02 | Composiciones farmaceuticas que contienen peptidos del grupo de la colecistoquinina-ceruleina para la terapia de estados de shock y de insuficiencias respiratorias y cardiocirculatorias. |
Country Status (8)
Country | Link |
---|---|
US (1) | US4794103A (es) |
EP (1) | EP0239716B1 (es) |
JP (1) | JP2534998B2 (es) |
AT (1) | ATE87485T1 (es) |
DE (1) | DE3785066T2 (es) |
ES (1) | ES2053454T3 (es) |
IT (1) | IT1204430B (es) |
ZA (1) | ZA87149B (es) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1218472B (it) * | 1985-08-30 | 1990-04-19 | Alfio Bertolini | Composizioni farmaceutiche comprendenti acht (1-24) per il trattamento terapeutico degli stati di shock e dell'insufficienza respiratoria e cardiocircolatoria |
EP0522596A1 (en) * | 1989-04-03 | 1993-01-13 | Kabi Pharmacia AB | Method and means for inducing constriction of the pupil in the eye |
SE8901149D0 (sv) * | 1989-04-03 | 1989-04-03 | Pharmacia Ab | Medel foer inducering respektive foerhindrande av pupillkonstriktion i oegat |
CA2140241A1 (en) * | 1992-07-15 | 1994-02-03 | Thomas N. Thomas | Blood levels of cck peptides relative to panic disorder treatment |
US6558952B1 (en) * | 1992-12-14 | 2003-05-06 | Waratah Pharmaceuticals, Inc. | Treatment for diabetes |
US20040001842A1 (en) * | 1997-05-12 | 2004-01-01 | Dov Michaeli | Immunogenic compositions to the CCK-B/gastrin receptor and methods for the treatment of tumors |
JP2002515458A (ja) * | 1998-05-15 | 2002-05-28 | アフトン・コーポレーシヨン | 高ガストリン血症の予防および処置 |
DE69916273T2 (de) * | 1998-06-18 | 2005-05-19 | Vecta Ltd. | Verwendung von gastrin fragmenten oder sythetischen analogen von gastrin zur herstellung eines arzneimittels zur behandlung der helicobacter pylori assozierten störungen |
SE9901578D0 (sv) * | 1999-05-03 | 1999-05-03 | Karolinska Innovations Ab | New use of substance in PNS |
US20030091574A1 (en) | 2001-03-23 | 2003-05-15 | Gevas Philip C. | Combination treatment of pancreatic cancer |
US20090191232A1 (en) | 2001-05-04 | 2009-07-30 | Gevas Philip C | Combination therapy for the treatment of tumors |
US6810583B2 (en) * | 2001-08-07 | 2004-11-02 | International Business Machines Corporation | Coupling of conductive vias to complex power-signal substructures |
US6803046B2 (en) * | 2002-08-16 | 2004-10-12 | Bracco International B.V. | Sincalide formulations |
US7235376B2 (en) * | 2003-03-28 | 2007-06-26 | Receptor Biologix, Inc. | Gastrin hormone immunoassays |
ES2400058T3 (es) | 2004-09-22 | 2013-04-05 | Cancer Advances, Inc. | Anticuerpos monoclonales para progastrina |
US20080077949A1 (en) * | 2006-09-22 | 2008-03-27 | Inventec Corporation | Rotating data storage device anti-shake mechanism |
EP3624841A4 (en) | 2017-06-15 | 2021-01-27 | Cancer Advances, Inc., | COMPOSITIONS AND METHODS OF INDUCING HUMORAL AND CELLULAR IMMUNITIES AGAINST TUMORS AND CANCER |
RU2667466C1 (ru) * | 2017-11-27 | 2018-09-19 | Общество с ограниченной ответственностью "МЕДИНВЕСТ" | Пептидное соединение, восстанавливающее функцию органов дыхания и обладающее иммуномодулирующим действием |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3723406A (en) * | 1969-12-23 | 1973-03-27 | Squibb & Sons Inc | Novel peptides having cholecystokinin activity and intermediates therefor |
DE2256445C3 (de) * | 1972-11-17 | 1981-11-05 | Hoechst Ag, 6000 Frankfurt | Heptapeptide, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Präparate |
DE3138233A1 (de) * | 1981-09-25 | 1983-04-07 | Farmitalia Carlo Erba S.p.A., 20159 Milano | Neuropsychotropisches arzneimittel |
-
1986
- 1986-01-10 IT IT19055/86A patent/IT1204430B/it active
-
1987
- 1987-01-02 DE DE8787100015T patent/DE3785066T2/de not_active Expired - Fee Related
- 1987-01-02 US US07/000,184 patent/US4794103A/en not_active Expired - Lifetime
- 1987-01-02 AT AT87100015T patent/ATE87485T1/de active
- 1987-01-02 ES ES87100015T patent/ES2053454T3/es not_active Expired - Lifetime
- 1987-01-02 EP EP87100015A patent/EP0239716B1/en not_active Expired - Lifetime
- 1987-01-07 JP JP62001573A patent/JP2534998B2/ja not_active Expired - Lifetime
- 1987-01-09 ZA ZA87149A patent/ZA87149B/xx unknown
Also Published As
Publication number | Publication date |
---|---|
EP0239716A3 (en) | 1990-05-23 |
JPS62246521A (ja) | 1987-10-27 |
US4794103A (en) | 1988-12-27 |
DE3785066D1 (de) | 1993-05-06 |
IT8619055A0 (it) | 1986-01-10 |
DE3785066T2 (de) | 1993-07-08 |
EP0239716A2 (en) | 1987-10-07 |
JP2534998B2 (ja) | 1996-09-18 |
ATE87485T1 (de) | 1993-04-15 |
ZA87149B (en) | 1987-09-30 |
IT1204430B (it) | 1989-03-01 |
EP0239716B1 (en) | 1993-03-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2053454T3 (es) | Composiciones farmaceuticas que contienen peptidos del grupo de la colecistoquinina-ceruleina para la terapia de estados de shock y de insuficiencias respiratorias y cardiocirculatorias. | |
DE68917219D1 (de) | Therapeutisches Erzeugnis zur Behandlung von Beschwerden während der oder nach den Wechseljahren. | |
NO873244L (no) | Legemiddel. | |
PT91246A (pt) | Processo para a preparacao de composicoes farmaceuticas para administracao endovenosa, contendo ciclosporina como ingrediente activo | |
UY23561A1 (es) | Procedimiento para la preparacion de tnf-muteinas | |
ES2194376T3 (es) | Preparacion especifica de sitio de conjugados de polietilenglicol-grf. | |
IL68938A (en) | Nonapeptide and decapeptide analogs of lhrh,their preparation and pharmaceutical compositions containing them | |
ES2031805T1 (es) | Derivados del t-4 soluble. | |
PT83933B (pt) | Processo para a preparacao de composicoes estaveis de activador do plasminogenio humano, tipo tecido | |
NO873699L (no) | Polypeptid som er egnet til dempning, behandling og diagnostisering av autoimmune lidelser saasom leddbetennelser. | |
IT1170214B (it) | Composizione farmaceutica per la cura delle arteriopatie periferiche | |
ES2057225T3 (es) | Una composicion para la preparacion de una vitamina d3 activa en forma de dosificacion y su procedimiento de preparacion. | |
ES2133295T3 (es) | Peptidos ciclicos y su uso. | |
PT95697A (pt) | Processo para a preparacao de composicoes farmaceuticas contendo substancias antiandrogenicamente activas | |
IT8349450A0 (it) | Determinate pirazolo-chinoline sostituite, procedimento per la loro preparazione, preparati farmaceutici contenenti questi composti e loro impiego terapeutico | |
ES8306483A1 (es) | Procedimiento de preparacion de las dibezooxepinas sustituidas y de sus sales de adicion con un acido mineral u organico | |
NO995944L (no) | Anti-arrytmisk blanding og fremgangsmåter for behandling | |
EP0230264A3 (en) | Pharmaceutical composition for nasal application, process for its preparation and its use | |
ES2108684T3 (es) | Analogo de la hormona de liberacion de la hormona luteinizante (lhrh). | |
DE3770766D1 (de) | Wirkstoffe zur anwendung bei der behandlung von tumoren. | |
FI811682L (fi) | Lh-rh antagonister | |
IL85189A (en) | Beta-alkyl substituted melatonins,their preparation and pharmaceutical compositions containing them | |
ES2196456T3 (es) | Compuestos ciclicos de cinco eslabones en el anillo condensado que llevan un grupo sulfonamida, su uso como medicamentos y composiciones farmaceuticas que los contienen. | |
IL70152A (en) | Growth-promoting active peptides,their preparation and pharmaceutical and veterinary compositions containing them | |
ZA843489B (en) | 4-oxothiazolidin-2-ylidene-acetamide derivatives,processes for their preparation and their use in the combating of diseases of the central nervous system |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 239716 Country of ref document: ES |